Health Condition 1: L648- Other androgenic alopecia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Age group 18-50 years Presenting with patterned hair loss Males - norwood hamilton grade 3,4,5 Patients who have not taken medical treatment for aga in any form for the last 6 months
Exclusion criteria
Exclusion criteria: Patients with alopecia other than androgenetic alopecia Patient with active infection at the local site Patient have keloidal tendency Patient with blood coagulopathies Platelet count less than 1.5 lac/ul Patients who are immunocompromised(hiv, malignancy, steroid or chemotherapy)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Efficacy and safety of injectable platelet rich fibrin therapy and topical minoxidil(5%) fortified with finasteride(0.1%) in the treatment of androgenetic alopeciaTimepoint: 52 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| reported adverse events of the procedure in both intervention & comparator agentTimepoint: 52 weeks | — |
Countries
India
Contacts
Dr Rajendra Prasad Government Medical College Kangra at Tanda